Navigation Links
Cytokine Resistance Contributes to Pathology of Type 2 Diabetes

A new study by University of Illinois researchers describes how an impaired anti-inflammatory response plays a role in the pathology of type 2 diabetes .

Published in the Journal of Immunology, the study focused on a number of cytokines, protein signals that bind to specific receptors on cells and set off a cascade of biochemical reactions within the cell.

Interleukins, interferons, tumour necrosis factors, and some growth factors are among the cytokines that direct many aspects of the immune response say the researchers.

Previous studies had shown that that macrophages in diabetic and obese (diabese) mice secrete more pro-inflammatory and less anti-inflammatory cytokines than those of non-diabese mice.

In the new study, led by pathology professor and department head Gregory Freund, the researchers demonstrated that human monocytes cultured under type 2 diabetic conditions had impaired interleukin-4 signalling, an important player in the immune response in that it steers macrophages toward the production of other anti-inflammatory cytokines.

Boffins say when IL-4 binds to its receptor on a target cell, it sets off one of two cascades of intracellular events, the first of which signal transduction pathways, the Jak-STAT pathway. But the scientists were more interested in knowing about the second pathway, called the insulin receptor substrate 2 / phosphatidylinositol-3 kinase (IRS-2/PI3K), which was more of a mystery.

One of the actions of diabetes is to create intracellular insulin resistance. Some of the cytokines that work on cells share the same pathways as the insulin receptor, Freund said.

The study showed that the IRS-2 signalling arm of the interleukin-4 pathway directed the up-regulation of a key anti-inflammatory molecule in primary macrophages, and that the pathway was disrupted in type 2 diabetic conditions.

It also found that the loss of IL-4 fu nction in diabese mice caused chronic over-expression of an important suppressor of cytokine signalling (SOCS) protein, which aborts the cascade of events that normally leads to insulin uptake and/or cytokine signalling in a balanced inflammatory response.

According to Freund, the study supports earlier findings that inflammation is a key part of the pathology of diabetes.

The researchers say that pro-inflammatory cytokines are elevated in type 2 diabetes, but the anti-inflammatory mechanisms are also impaired, leading to a multitude of major and minor health issues in the diabese.

They get a cold. They get injured. Something happens. And its worse in those people with obesity or diabetes and lasts longer than it does in others. Why? The imbalance may be the elevation in pro-inflammation. But it probably also includes a loss of anti-inflammatory function, Freund said.


'"/>




Related medicine news :

1. Experimental Drug Causes Cytokine Storm
2. Drexel Research in Cytokines Could Treat Sepsis
3. Link between birth weight and Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Easier Methods Required to Screen Insulin Resistance
6. Insulin Resistance Linked To Difference In Gender
7. Adopting Easier Methods To Screen Insulin Resistance
8. Drug Resistance Questioned in Patients With Chronic Sinusitis
9. Understanding Insulin Resistance
10. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
11. Junk Food Causes High Level Of Insulin Resistance In Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... ... 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad am ... against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena known ... Ring consists of some 73 curves, stretching out over more than 500 meters of ...
(Date:7/27/2017)... (PRWEB) , ... July 28, 2017 , ... ... Syngenta on an upcoming episode of the award-winning television series, American Famer, scheduled ... on RFD-TV. , Syngenta is dedicated to helping humanity face its toughest ...
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... 2017 , ... GAFFEY Healthcare, a leading provider of revenue ... Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President ... officer (CEO). , Elrene has been with company since Oct 2014 and previously ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: